European Archives - Page 696 of 899 - European Medical Journal

Continue
21 Mins
8th June 2017

Review of the 52nd International Liver Congress™ 2017

The diverse city of Amsterdam, Netherlands, hosted this year’s International Liver CongressTM (ILC) of the European Association for the Study of the Liver…
2 Mins
8th June 2017

The Importance of Civil Society Involvement in Eliminating Hepatitis C

This is an historic moment for hepatitis C treatment. With the advent of direct-acting antivirals (DAAs), we can now massively reduce the harm from an…
June 2017

EMJ Hepatology 5.1 2017

Welcome to the latest edition of our EMJ Hepatology eJournal! This issue is jam-packed with the latest hepatological updates, including cutting edge…
10 Mins
8th June 2017

A Discussion on the Management of Wilson Disease

Prof Peter Ferenci opened the meeting by providing a background to Wilson disease (WD), an enigmatic condition where no two cases are the same. He explored…
1 Mins
8th June 2017

Statins in Cirrhosis and Portal Hypertension

Statins have been used for almost three decades as cholesterol lowering drugs, yet additional effects…
10 Mins
8th June 2017

Special Poster Feature: American Association for the Study of Liver Diseases (AASLD): The Liver Meeting® 2016 Coverage

The Liver Meeting®, the official meeting of the American Association for the Study of Liver Diseases (AASLD), held in Boston, Massachusetts, USA…
2 Mins
8th June 2017

Magnetic Resonance Imaging of Diffuse Liver Diseases

Virtual liver biopsy (VLB) can be considered a multicomponent imaging biomarker able to provide fundamental information on the presence, distribution…
1 Mins
8th June 2017

Adenosine 2A Receptor Stimulation Prevents the Multiple Processes That Lead to Hepatic 'Immuno-Lipotoxicity' in Mice Fed a Methionine Choline-Deficient Diet and Blocks Non-Alcoholic Steatohepatitis Development

Non-alcoholic fatty liver disease (NAFLD) is a benign condition, but in ~20% of patients it can evolve into non-alcoholic steatohepatitis (NASH) with…
4 Mins
8th June 2017

Beta-Blockers in Prevention of Development of Varices and Variceal Bleeding in Cirrhosis: Current Management, Controversies, and Future Directions

One of the major complications of cirrhosis is the development of portal hypertension and variceal bleeding. Varices develop at a rate of 5% per year…
1 Mins
8th June 2017

A New Screening Strategy for Varices by Liver and Spleen Stiffness Measurements in Cirrhotic Patients: A Randomised Controlled Trial

Variceal screening with upper endoscopy is recommended in cirrhotic patients but unfortunately is costly, uncomfortable to patients, and has low uptake.